Feb 15, 2023 / 01:40PM GMT
Joseph Schwartz - SVB Securities - Analyst
Hello. Welcome to this presentation by Pharvaris. We have Morgan Conn, Chief Business Officer; and Wim Souverijns, Chief Commercial Officer with us today. Thanks so much for giving us the update, and we'll have time for Q&A at the end. Take it away.
Morgan Conn - Pharvaris NV - Chief Business Officer
Thank you, Joe. I appreciate the opportunity for the invitation and the opportunity to speak today. So as a reminder, we'll be making forward-looking statements today, and for further details, we refer you to our SEC filings on that.
So Pharvaris was founded to bring to people living with HAE new oral products and options. We've assembled the team you see here with talent across the pharma value chain. And most notably, we'd point to the leaders who are behind the two most successful products, both for prophylaxis and on-demand treatment of HAE. So we feel we've got it have a good pool to build the products that we're looking to do here.
HAE, itself, for those -- as a bit of a background is a rare,
Pharvaris NV at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 15, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers